SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 43 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $166,000 | -70.1% | 400,140 | +43.8% | 0.04% | -47.9% |
| Q3 2018 | $556,000 | -48.8% | 278,184 | -45.7% | 0.07% | -57.7% |
| Q2 2018 | $1,086,000 | +135.6% | 512,036 | +309.6% | 0.17% | +300.0% |
| Q4 2017 | $461,000 | -2.5% | 125,000 | -48.7% | 0.04% | +35.5% |
| Q3 2017 | $473,000 | +19.7% | 243,638 | +66.7% | 0.03% | +19.2% |
| Q2 2017 | $395,000 | -37.5% | 146,138 | -5.2% | 0.03% | -23.5% |
| Q1 2017 | $632,000 | -21.1% | 154,162 | -30.3% | 0.03% | -27.7% |
| Q4 2016 | $801,000 | – | 221,326 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,600,000 | $1,092,000 | 1.15% |
| BVF INC/IL | 2,287,860 | $951,000 | 0.12% |
| Eventide Asset Management | 2,265,455 | $942,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 400,140 | $166,000 | 0.04% |
| RP Management, LLC | 129,517 | $54,000 | 0.04% |
| Palo Alto Investors LP | 1,162,473 | $483,000 | 0.03% |
| NEA Management Company, LLC | 1,298,274 | $539,000 | 0.02% |
| Rhenman & Partners Asset Management AB | 377,244 | $157,000 | 0.02% |
| GREAT POINT PARTNERS LLC | 317,962 | $132,000 | 0.02% |
| Vivo Capital, LLC | 195,474 | $81,000 | 0.01% |